18 Jan

Analysts’ Ratings for Shell before Its Earnings

WRITTEN BY Maitali Ramkumar

Analysts’ ratings for Shell

In this series, we reviewed Royal Dutch Shell’s (RDS.A) 4Q17 estimates, segment-wise prospects, stock returns, moving averages, and stock price forecast before of its earnings release on February 1, 2018. Now, we’ll assess analysts’ ratings for Shell.

Analysts’ Ratings for Shell before Its Earnings

Shell is rated by 11 Wall Street analysts. Of the analysts, ten (or 91%) assigned “buy” or “strong buy” ratings, while one assigned a “hold” rating. None of the analysts assigned “sell” or “strong sell” ratings.

ExxonMobil (XOM), Chevron (CVX), and BP (BP) have been rated as a “buy” by 32%, 63%, and 46% of the analysts, respectively. Other global integrated firms like Total (TOT), YPF (YPF), and Petrobras (PBR) have been rated as a “buy” by 17%, 100%, and 50% of the analysts, respectively.

Analysts are positive about Shell

Shell intends to reduce its debt by pulling its four levers—divestment, capex cut, cost reduction, and new projects. It appears that Shell has started to yield results from this strategy. Shell has decreased its debt from the highs experienced in 3Q16. For Shell, 9M17 has been a fantastic period compared to 9M16 in terms of cash flows.

Shell expects to continue this strategy until 2020 in order to achieve its targeted free cash flows. On debt reduction and liquidity improvement, Shell’s CEO Ben Van Beurden, in its latest transcript, said, “Over the last few years we have established tremendous clarity of purpose – inside the company and I trust also for our stakeholders. We have developed a differentiated strategy that gives us competitive advantage, and we are re-shaping the portfolio profoundly to align to that strategy. And I clearly see it is working, over the last 2 years we have transformed the financial metrics of our business.”

If Shell continues to follow its plan, then it could be a strong company capable of generating huge returns for its stakeholders. As a result, analysts have a favorable opinion on Shell.

Latest articles

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.

Walt Disney’s (DIS) latest movie, Toy Story 4, has reportedly broken records in the opening weekend with $118 million in sales. However, the opening weekend collection was behind analysts’ expectations of at least $150 million in the first weekend.

24 Jun

Will Home Depot’s Upward Momentum to Continue?

WRITTEN BY Rajiv Nanjapla

As of June 21, Home Depot (HD) was trading at $209.39, which implies a rise of 9.7% since the announcement of its first-quarter earnings on May 21. Also, the company was trading at a premium of 32.4% from its 52-week low of $158.09 and a discount of 2.8% from its 52-week high of $215.43.

On June 21, Aurora Cannabis (ACB) made an announcement that indicated that it will move towards higher margin vape products. In addition, the company also believes concentrates and edibles will command higher margins. In anticipation of this development, the company announced the expansion of its facility to capitalize on growth related to these segments.

Shares of Mondelēz International (MDLZ) are scaling new heights thanks to its stellar gains so far this year. Mondelēz stock is up 38.0% on a YTD (year-to-date) basis, and it closed at $55.25—just a shade lower than its 52-week high of $55.71—on June 21.

24 Jun

How Long Will Facebook's Libra Fuel Bitcoin Rally?

WRITTEN BY Mayur Sontakke, CFA, FRM

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries.